Potassium channels have been identified as targets for a large number of therapeutic indications. The ability to use a highthroughput functional assay for the detection and characterization of small-molecule modulators of potassium channels is very desirable. However, present techniques capable of screening very large chemical libraries are limited in terms of data quality, temporal resolution, ease of use, and requirements for specialized instrumentation. To address these issues, the authors have developed a fluorescence-based thallium flux assay. This assay is capable of detecting modulators of both voltageand ligand-gated potassium channels expressed in mammalian cells. The thallium flux assay can use instruments standard to most high-throughput screening laboratories, and using such equipment has been successfully employed to screen large chemical libraries consisting of hundreds of thousands
INTRODUCTION
P OTASSIUM (K + ) CHANNELS ARE A LARGE CLASS of cation channels important in regulating such processes as heart rate, hormone secretion, neurotransmitter release, electrolyte and water balance, and cell division/proliferation. Given their physiological importance, K + channels have emerged as targets of drug discovery efforts for such indications as diabetes, epilepsy, pain, immunomodulation, arrhythmia, dementia, and others. 1, 2 The utility of fluorescent indicators for measuring changes in intracellular divalent cation concentrations, particularly calcium (Ca 2+ ), for both basic research and drug discovery endeavors is well documented. 3, 4 However, unlike for divalent and nonselective cation channels, there are not any generally useful fluorescent indicators for measuring ion flux through potassium channels in living cells. The use of the dyes that do exist, such as potassium-binding benzofuran isophthalate (PBFI), 5 is not well suited to the evalua-tion of large chemical libraries in a high-throughput screening (HTS) environment due to their UV excitation spectra, which overlap with many optically active small molecules, and also due to the small signals generated by these dyes.
The activity of K + channels is most often assessed using slow, serial approaches, such as electrophysiology, or less informationrich approaches, such as radioactive rubidium (Rb + ) flux assays, nonradioactive Rb + flux assays, or voltage-sensitive dyes that measure the change in membrane potential that may be associated with changes in K + channel activity. 6 Relative to fluorescence-based ion flux indicators, all of the above techniques are deficient in one or more of the following: throughput, temporal resolution, sensitivity, or selectivity. Although parallel, automated voltage clamp technology is rapidly evolving, 7 there still remains a need for robust high-throughput methods for identifying and assessing the activity of potassium channel modulators from large chemical libraries.
To address this shortcoming in assay technology related to K + channels, we examined the utility of thallium flux (Tl + ). The permeability of Tl + through K + channels is well known, 8, 9 and assays based on the Tl + -sensitive fluors have even been described. [10] [11] [12] [13] [14] However, the fluors and the assays developed from them have not been widely adopted because they have low utility due to the spectral properties of the dyes, small signals, and the poor solubility of Tl + in chloride (Cl -)-containing buffer systems. 14 The present study describes a Tl + -sensitive fluorescent dye and a buffer system that largely overcome the deficiencies of prior techniques, yielding an assay system capable of allowing rapid, facile, accurate, and precise measurements of K + channel activity suitable for screening large chemical libraries.
MATERIALS AND METHODS

Reagents
All acetomethoxy (AM) esters of metal-chelating dyes, including BTC-AM, were obtained from Molecular Probes (Eugene, OR). XE-991 and Retigabine were synthesized at Bristol-Myers Squibb. Apamin and all buffer constituents were purchased from Sigma Chemical Company (St. Louis, MO). Ionomycin was purchased from Calbiochem (La Jolla, CA). G418 and Minimal Essential Medium were purchased from Invitrogen Life Technologies (Carlsbad, CA). Fetal bovine serum was purchased from JRH Biosciences (Lenexa, KS).
Cell culture
HEK-293 cells were grown in Minimal Essential Medium containing 10% (v/v) fetal bovine serum at 37°C in a 5% CO 2 incubator. HEK-293 cells stably expressing rSK3 and mKCNQ2 were grown in the same medium with the addition of 500 µg/mL G418.
Thallium flux assays of potassium channels expressed in HEK-293 cells
HEK-293 cells expressing the ion channels of interest were plated in 384-well, black-walled, clear-bottomed, poly-D-lysinecoated plates (BD Biosciences, Bedford, MA) at a density of 20,000 cells/well in 20 µL of Minimal Essential Medium containing 10% (v/v) fetal bovine serum and incubated overnight at 37°C in a 5% CO 2 incubator. Prior to assay, cells were loaded with the AM ester of one of many metal-sensitive fluors, including BTC-AM. Cell loading was accomplished by removing the culture medium and replacing it with 40 µL/well of the AM ester of the dye (2 µM) mixed with an isotonic solution containing (in mM) 140 sodium gluconate, 2.5 potassium gluconate, 3.6 hemi-calcium gluconate, 2 hemi-magnesium gluconate, 5 glucose, and 10 HEPES, pH 7.3 (Cl --free assay buffer). Dye loading was allowed to proceed from 30 to 120 min at room temperature, at which time the dye-loading solution was removed and replaced with 40 µL/well of Cl --free assay buffer.
Cells loaded with dye were loaded onto a FLIPR384 (Molecular Devices, Sunnyvale, CA). Fluors were excited using the 488-nm line of an argon laser. Emission was filtered using a 540 ± 30-nm bandpass filter. For rSK3-expressing cells, the assay was initiated by the addition of 10 µL/well of Cl --free assay buffer containing 2.5 mM Tl 2 SO 4 and 5 µM ionomycin. For mKCNQ2expressing cells, the assay was initiated by the addition of 10 µL/ well Cl --free assay buffer containing either 18.75 mM K 2 SO 4 and 7.5 mM Tl 2 SO 4 (activator assay) or 50 mM K 2 SO 4 and 25 mM Tl 2 SO 4 (inhibitor assay). For all assays, data were collected at 1 Hz for 10 sec, at which time the Tl + -containing stimulus buffers were added. Data from individual assay wells were normalized by dividing each data point by the average of the first 5 values recorded prior to stimulus addition.
For evaluation of the effects of ion channel modulators using the Tl + flux assay, compounds to be tested were dissolved in DMSO (Retigabine and XE-991) or Cl --free assay buffer (apamin). Serial dilutions in DMSO or Cl --free assay buffer (as appropriate) were prepared in 384-well polystyrene plates using a SerialMate (Matrix Technologies, Hudson, NH). Then, 1 µL of diluted compound was transferred to a 384-well polystyrene plate, to which was added 100 µL/well Cl --free assay buffer using a Multidrop Stacker (Titretek Instruments, Huntsville, AL). Dyeloading solution was aspirated from plates containing cells loaded with BTC using an EMBLA plate aspirator (Skatron Instruments, Norway) and replaced with 40 µL/well of the diluted test compound solution. Assays were initiated and data collected as described above.
High-throughput library screening using the Tl + flux assay
For screening of compound libraries, the Tl + flux assay was performed essentially as described above with the following modifications. Cells were plated as described above using a Multidrop Stacker and incubated overnight at 37°C in a 5% CO 2 incubator. Growth medium was removed by aspiration with an EMBLA plate aspirator, and BTC-AM solution was added with a Multidrop Stacker for the mKCNQ2 assays or a Multidrop (Thermo Electron, Waltham, MA) for the rSK3 assay. Following a 1-h incubation, the BTC-AM solution was removed by aspiration with the EMBLA plate aspirator and replaced with 40 µL/well of diluted test compound.
Test compounds were prepared as follows: 1 µL/well of 1-mM solutions in DMSO from the BMS compound collection was supplied in 384-well polypropylene plates from the BMS compound management unit. Compounds were diluted just in time for assay with 100 µL/well Cl --free assay buffer using a 384-tip CyBi-Well pipettor (CyBio, Jena, Germany). This dilution produces a final DMSO concentration of 1% (v/v), which was determined to be at the upper limit of the assay's DMSO tolerance.
Following addition of test compounds, the assay plates were transferred to the fluorescent imaging plate reader (FLIPR), and the assays were initiated as described above. For the mKCNQ2 screens, the assays were performed by an individual operator processing stacks of 20 plates at a time. For the rSK3 screen, the assay process was completely automated. Plates were transferred between instruments with a track-mounted CRS robotic arm (Thermo Electron, Waltham, MA) controlled using CRS Polara scheduling software. For all assays, data were automatically transferred to a remote server and analyzed in real time. Assay performance was judged by the activity of 32 vehicle controls wells and 32 wells containing a fully effective concentration of an appropriate positive control compound present on each screening plate.
Voltage clamp assays of potassium channels expressed in HEK-293 cells
HEK-293 cells expressing either mKCNQ2 or rSK3 were plated in 35-mm poly-D-lysine-coated plates (BD Biosciences, Bedford, MA) in Minimal Essential Medium plus 10% (v/v) fetal bovine serum. After plating, cells were incubated overnight at 37°C in a 5% CO 2 incubator. Whole-cell current measurements were recorded with pipettes (tip diameter 1-2 µm) pulled from 1.5-mm internal diameter borosilicate glass capillaries (Garner Glass, Claremont, CA) using a Model P80-PC micropipette puller (Sutter, Novato, CA) and tip polished to open pipette resistances of 2.5 to 4 MΩ in the extracellular solution described above. Intracellular solution for whole-cell recordings contained the following (in mM): 5 EGTA, 150 KCl, 1.0 MgCl 2 , 2.5 CaCl 2 , 10 HEPES (pH 7.3) w/KOH, and 290 to 300 mOsM. Drugs were applied to cells by local superfusion via forced perfusion. mKCNQ2or rSK3-expressing HEK-293 cells were voltage-clamped with an EPC-9 patch clamp amplifier (HEKA Elektronik, Germany). The membrane currents stimulated using HEKA software (Pulse version 8.6) were filtered at 1 kHz (-3 dB) using the EPC-9's integrated 4-pole low-pass Bessel filter, digitized at 5 kHz with the integrated ITC-16 analog-to-digital converter.
Changes in mKCNQ2 current amplitude produced by K + compounds were measured from either steady-state currents at -40 mV (openers) or the steady-state currents evoked by a 700-ms step to +20 mV (inhibitors) from a holding potential of -80 mV. The rSK3 currents were stimulated by 160-ms voltage ramps from -110 to -20 mV, following several minutes of whole-cell dialysis with an internal pipette solution similar to the one described above for KCNQ2 currents in which the free Ca 2+ was buffered to 1 µM. The effects of compounds were measured relative to the control current amplitude recorded at -20 mV, and these data were used to construct concentration-inhibition curves from which the IC 50 value was estimated. As part of each experiment, a saturating concentration of dequalinium, a fully reversible reference SK3 inhibitor, was applied to calibrate the amount of SK3 current in the whole-cell record and to allow efficacy ranking of test compounds. Concentration response data were generated from the difference in the steady-state current amplitude in the presence of test compound relative to the basal current.
For electrophysiology experiments, the compounds were dissolved and diluted as described for the Tl + flux assay, except the Cl --free assay buffer was replaced by a solution containing (in mM) 140 NaCl, 2.5 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 5 glucose, 10 HEPES (pH 7.3), and 305 to 310 mOsM (external solution).
Data analysis
Concentration-response curves for both Tl + flux and electrophysiology data were fit using Excel Fit (ID Business Solutions Limited, Surrey, UK) using a single-site logistic equation. Data were analyzed by fitting maximum amplitudes of change in fluorescence (for Tl + flux) or current (for voltage clamp) for a given condition of test compound. Potencies of compounds were calculated from the average of 3 assay wells for Tl + flux measurements or a minimum of 3 individual cells for voltage clamp experiments.
RESULTS
The cell-permeant AM esters of a large number of metalsensitive fluorescent dyes are commercially available. To determine whether any of these were suitable as a Tl + sensors, the dyes were loaded into HEK-293 cells heterologously expressing the small-conductance calcium-activated potassium channel (rSK3). Because Tl + has a solubility limit of~5 mM in Cl --containing buffers at room temperature, a substantially Cl --free assay buffer was formulated. This isotonic buffer contains the gluconate salts of the major cations typically found in isotonic saline solutions. Thallium sulfate is freely soluble in this buffer up to 100 mM. The rSK3 channels in dye-loaded cells in the Cl --free assay buffer were stimulated to open by the addition of ionomycin, which increases intracellular Ca 2+ , leading to channel opening. A significant number of the dyes tested were observed to be affected by the addition of Tl + (1 mM) to the bath (data not shown). Of these, BTC was selected for further evaluation based on the fact that it showed a substantial increase in fluorescence upon Tl + addition, it produced a strong signal on the FLIPR, and its fluorescence was only weakly affected by even large changes in intracellular Ca 2+ (BTC K d for Ca 2+ = 7 µM). Furthermore, the effect of Ca 2+ on BTC fluorescence elicited by excitation at 488 nm is opposite in sign when compared to Tl + . Thallium causes an increase in fluorescence, whereas Ca 2+ causes a decrease. Figure 1 shows the change in fluorescence that results from exposing BTC-loaded rSK3-expressing HEK-293 cells to 1 mM Tl + in the presence and absence of 1 µM ionomycin. Neither the presence of ionomycin or Tl + alone produced a substantial change in the BTC fluorescence during the time course of the experiment. However, the presence of both ionomycin and Tl + resulted in a dramatic increase in BTC fluorescence that was fully inhibited by a 100-nM concentration of the peptide-based SK inhibitor, apamin.
Following the demonstration that the BTC could detect the Tl + influx mediated by the activation of rSK3 channels, we attempted to determine whether the technique could generate graded responses suitable for determining the potencies and efficacies of ion channel modulators. Figure 2A shows the raw data traces resulting from a Tl + -dependent increase in BTC fluorescence in rSK3expressing HEK-293 cells in the presence of varying concentrations of apamin. When the peak amplitudes of the change in fluorescence are plotted, they can be readily fit to a single-site logistic equation (Fig. 2B) . The fit yields an IC 50 of 100 ± 10 pM (SEM, n = 3). This value is consistent with values obtained using the wholecell voltage clamp technique, 60 ± 5 pM (SEM, n = 3).
To determine the potential utility of BTC and the Tl + flux technique to measure the activity of voltage-gated potassium channels, we chose to investigate HEK-293 cells expressing the Fluorescent Tl + Flux Assay for K + Channels noninactivating delayed recifier, mKCNQ2. The addition of 9.5 mM extracellular K + and 3 mM extracellular Tl + resulted in a marked increase in BTC fluorescence in HEK-293 cells expressing mKCNQ2 compared to untransfected HEK-293 cells (Fig.  3A) . The mKCNQ2 and Tl + -dependent effects on BTC fluorescence could be modulated by the known mKCNQ2 modulators Retigabine and XE-991. Figure 3B shows the data obtained from mKCNQ2 activated by the addition of 9.5 mM external K + and 3 mM Tl + in the presence of varying concentrations of the KCNQ activator, Retigabine. The fit of the Retigabine data yields an EC 50 of 0.6 ± 0.06 µM (SEM, n = 3). This value is in close agreement to the value obtained from whole-cell voltage clamp measurements of mKCNQ2-expressing HEK-293 cells made at -40 mV, 0.4 ± 0.02 µM (SEM, n = 3). Figure 3C shows the fit to data obtained from activating mKCNQ2 by the addition of 10 mM external Tl + and 20 mM external K + in the presence of varying concentrations of the KCNQ inhibitor, XE-991. The fit yields an IC 50 of 0.2 ± 0.008 µM (SEM, n = 3). This value closely agrees with whole-cell voltage clamp measurements of mKCNQ2 made at +20 mV, 0.3 ± 0.1 µM (SEM, n = 3).
For the Tl + flux technique to be of high utility for the identification of potassium channel modulators by the screening of large chemical libraries, the technique would need to be robust, possess a high signal-to-noise ratio, be easy to perform, and be amenable to automation. To evaluate the Tl + flux technique's utility for HTS, we ran high-throughput screens of a large chemical library on a voltage-gated potassium channel, mKCNQ2, in both opener/agonist and inhibitor modes and an intracellular ligand-gated potassium channel, rSK3, in the inhibitor mode. The screening statistics for 3 high-throughput screens are shown in Table 1 . Throughputs in excess of 70,000 wells/operator/shift were achieved for the voltage-gated channel screen running in workstation mode with a single operator. The intracellular ligand-gated channel screen was run using a fully automated, unattended screening system. For all 
DISCUSSION
We have found that a number of fluorescent dyes are sensitive to Tl + . In particular, the benzothiazole-based BTC has both spec-tral properties and Tl + sensitivity that make it an excellent Tl + indicator for cell-based assays. Although BTC is sold as a calcium indicator, its relatively low affinity for Ca 2+ (K d = 7 µM) makes calcium-dependent changes in fluorescence insignificant when compared to the magnitude of the Tl + -dependent effects. In addition, although calcium binding causes a modest decrease in the fluorescence emission of BTC when the fluor is excited with 488nm light, Tl + causes up to a 2-fold increase in fluorescence. In conjunction with the identification of a superior, visible, light-excited Tl + -sensitive dye, we have formulated an isotonic, Cl --free extracellular solution that is both well tolerated by mammalian cells and permits the use of Tl + concentrations in assays in excess of 10 mM where required. However, when final Tl + concentrations in the range of 1 mM are acceptable, normal Cl -containing extracellular solutions may be used.
By combining the use of the BTC and Cl --free assay buffer, we have demonstrated that the Tl + flux technique is capable of generating concentration-dependent graded responses reflecting changes in potassium channel activity. Under the conditions tested for both rSK3, an intracellular ligand-gated potassium channel, and mKCNQ2, a voltage-gated potassium channel, the Tl + flux technique was able to accurately and precisely measure the potency of channel modulators when compared to the values obtained using the same compounds under voltage clamp conditions. When the Tl + flux technique was tested for its utility at screening large chemical libraries for potassium channel modulators, it proved to be quite robust and amenable to both workstation and fully automated screening approaches, with throughput suitable for easily screening compound libraries consisting of hundreds of thousands of samples. The signal-to-noise ratio of the assay was suitable on all days and in all conditions of screening tested, allowing the detection of a wide dynamic range of active compounds. In assay validation experiments, the assays for both the voltage-gated and the intracellular ligand-gated channel never failed to detect the activity of known modulators of the channels of interest. In addition, when more than 50 compounds, representing a dozen distinct chemotypes, identified using the Tl + flux technique from library screens were evaluated by electrophysiology, the compounds uniformly exhibited the opener or inhibitor activity predicted by the Tl + flux data.
In the future, dyes with higher affinity for Tl + or dyes with more dramatic Tl + -induced fluorescent changes may allow the utility of this technique to be expanded by allowing the use of lower Tl + concentrations, thus removing the need for Cl --free buffers, and the detection of very small changes in channel activity or the detection of pharmacological effects on poorly expressed channels. Such dyes may extend the utility of the technique for assaying channels expressed in native/primary cell populations.
Compared to other truly high-throughput functional techniques for measuring the activity of potassium channels, such as nonradioactive Rb + flux and voltage-sensitive dyes, the Tl + flux assay offers several advantages. These include measurement of flux and not membrane potential, high temporal resolution observable in real time, the ability to measure the channel activity in either single cells using fluorescence microscopy or populations of cells using plate readers, and the use of instruments already standard to most academic and drug discovery laboratories. Taken together, the qualities of the Tl + flux assay should allow it to play an important role in identifying and assessing the activity of potassium channel modulators. The Z′ column represents the mean Z′ value for each screen listed calculated from Z′ values generated for each plate in the screening run.
